Britto-Júnior José, Medeiros-Teixeira Lincoln Rangel, Lima Antonio Tiago, Dassow Letícia Costa, Lopes-Martins Rodrigo Álvaro Brandão, Campos Rafael, Moraes Manoel Odorico, Moraes Maria Elisabete A, Antunes Edson, De Nucci Gilberto
Department of Pharmacology, Faculty of Medical Sciences, University of Campinas (UNICAMP), Campinas 13083-970, Brazil.
Laboratory of Biophotonics and Experimental Therapeutics, University Evangélica of Goiás (UniEVANGÉLICA), Anápolis 75083-515, Brazil.
Life (Basel). 2023 Oct 4;13(10):2012. doi: 10.3390/life13102012.
6-nitrodopamine released from rat isolated atria exerts positive chronotropic action, being more potent than noradrenaline, adrenaline, and dopamine. Here, we determined whether 6-nitrodopamine is released from rat isolated ventricles (RIV) and modulates heart inotropism.
Catecholamines released from RIV were quantified by LC-MS/MS and their effects on heart inotropism were evaluated by measuring left ventricular developed pressure (LVDP) in Langendorff's preparation.
6-nitrodopamine was the major released catecholamine from RIV. Incubation with L-NAME (100 µM), but not with tetrodotoxin (1 µM), caused a significant reduction in 6-nitrodopamine basal release. 6-nitrodopamine release was significantly reduced in ventricles obtained from L-NAME chronically treated animals. 6-nitrodopamine (0.01 pmol) caused significant increases in LVDP and dP/dt, whereas dopamine and noradrenaline required 10 pmol, and adrenaline required 100 pmol, to induce similar increases in LVDP and dP/dt. The infusion of atenolol (10 nM) reduced basal LVDP and blocked the increases in LVDP induced by 6-ND (0.01 pmol), without affecting the increases in LVDP induced by 10 nmol of dopamine and noradrenaline and that induced by adrenaline (100 nmol).
6-nitrodopamine is the major catecholamine released from rat isolated ventricles. It is 1000 times more potent than dopamine and noradrenaline and is selectively blocked by atenolol, indicating that 6-ND is a main regulator of heart inotropism.
从大鼠离体心房释放的6-硝基多巴胺具有正性变时作用,其效力强于去甲肾上腺素、肾上腺素和多巴胺。在此,我们确定6-硝基多巴胺是否从大鼠离体心室(RIV)释放并调节心脏收缩力。
通过液相色谱-串联质谱法(LC-MS/MS)对RIV释放的儿茶酚胺进行定量,并通过测量Langendorff标本中的左心室舒张末压(LVDP)来评估它们对心脏收缩力的影响。
6-硝基多巴胺是RIV释放的主要儿茶酚胺。与L-NAME(100μM)孵育,但不与河豚毒素(1μM)孵育,会导致6-硝基多巴胺基础释放量显著降低。从长期接受L-NAME治疗的动物获得的心室中,6-硝基多巴胺的释放量显著减少。6-硝基多巴胺(0.01 pmol)可使LVDP和dP/dt显著增加,而多巴胺和去甲肾上腺素需要10 pmol,肾上腺素需要100 pmol才能诱导类似的LVDP和dP/dt增加。阿替洛尔(10 nM)的输注降低了基础LVDP,并阻断了6-ND(0.01 pmol)诱导的LVDP增加,而不影响10 nmol多巴胺和去甲肾上腺素以及100 nmol肾上腺素诱导的LVDP增加。
6-硝基多巴胺是从大鼠离体心室释放的主要儿茶酚胺。它的效力比多巴胺和去甲肾上腺素强1000倍,并被阿替洛尔选择性阻断,表明6-ND是心脏收缩力的主要调节因子。